Security key
34962G208
Forte Biosciences, Inc. - COMMON STOCK (FBRX)
CUSIP: 34962G208
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 13,521,022
- Total 13F value
- $350,237,410
- Share change
- +1,985,279
- Put/Call ratio
- 52%
- SEC-reported price per share
- $25.90
- Number of holders
- 68
- Value change
- +$50,671,169
- Number of buys
- 37
- Number of sells
- 26
- Shares outstanding
- 20,470,572
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
68
Top holders
10
FBRX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Forte Biosciences, Inc. SEC filings
Forte Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 34962G208
Recent filing periods:
Ownership snapshot
Top reported holders of FBRX - Forte Biosciences, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ALGER ASSOCIATES INC
Disclosed value leader
FEDERATED HERMES, INC.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 10%
13D/G row: ALGER ASSOCIATES INC
Showing 1-6 of 15 holder rows.
Quick read
ALGER ASSOCIATES INC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ALGER ASSOCIATES INC's linked filing trail.
Comparable ownership
Top 5
ALGER ASSOCIATES INC
10%
JANUS HENDERSON GROUP PLC
10%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
10%
Affinity Asset Advisors, LLC
7.3%
MPM BioImpact LLC
7.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ALGER ASSOCIATES INC |
13D/G
|
10%
|
$21,163,295
624,286 shares
|
-$34,238,356 | 31 Mar 2026 |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
Company
|
10%
|
$47,025,334
1,387,178 shares
|
-$1,308,777 | 31 Mar 2026 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13D/G
|
10%
|
$13,378,307
1,268,086 shares
|
+$6,618,184 | 30 Jun 2025 |
| Affinity Asset Advisors, LLC |
13F
13D/G
Company
|
7.3%
from 13D/G
|
$26,983,392
989,490 shares
|
— | 31 Dec 2025 |
| MPM BioImpact LLC |
13D/G
|
7.2%
|
—
1,000,682 shares
|
$0 | 31 Mar 2026 |
| Adage Capital Management, L.P. |
13D/G
|
6.8%
|
—
950,000 shares
|
$0 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
68
Shares
13,521,022
Rows available
68
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
59
Q1 2026 holders
68
Holder diff
9
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend